The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response announced it has activated its Emergency Prescription Assistance Program (EPAP) for Puerto Rico to give residents access to the critical prescription medications they need. The program pays for prescription medications for people without health insurance who are affected […]
While Puerto Rico is making progress in its effort to recover from the devastation left by the hurricanes, it remains a long process and there's a lot of work left to do. At the Food & Drug Administration, we're vigilant about helping address the challenges that remain.
Direct Relief, which for the past eight years has been supporting a network of nonprofit community health centers in Puerto Rico, delivered $21 million in medicines and medical products to the island over the weekend, the company confirmed.
The head of the U.S. Food and Drug Administration, Scott Gottlieb said this week the agency is “doing all it can” to support the immediate needs of Puerto Ricans after Hurricane María’s destruction, as well as ensure supplies of critical drugs produced on the island.
The U.S. Food and Drug Administration recently gave the go-ahead to two new drugs, Xeljanz and Quillivant XR, to treat rheumatoid arthritis and Attention Deficit Hyperactivity Disorder, respectively, the manufacturing companies announced in separate statements.
A Dow Jones/Factiva content provider since 2014
Subscribe to our Dollars & Sense podcast!
NIMB ON SOCIAL MEDIA